Schizophrenia Research
Clinical activity in schizophrenia focuses on adult participants and the long-term use of emraclidine and related investigational therapy programs.
- Psychiatric disorders
- Antipsychotic treatment development
- Long-term tolerability
The research interest centers on sustained treatment of psychotic disorders in adult populations.
Parkinson’s Disease Research
Work in Parkinson’s disease examines long-term administration of tavapadon for people living with Parkinsonian symptoms and motor impairment.
- Movement disorders
- Dopaminergic therapy
- Neurodegenerative disease management
This area reflects a focus on neurology and symptom control in chronic Parkinson’s disease.
Neuroscience and Central Nervous System Therapeutics
The sponsor’s portfolio is concentrated in central nervous system medicine, with programs spanning psychiatric and neurological conditions.
- Brain disorders
- Neuropsychiatry
- Motor and cognitive function
These efforts link neuroscience research with therapeutic development for chronic disorders affecting behavior and movement.
